论文信息 - International DLBCL Rituximab-CHOP Consortium Program demonstrates high-risk gene expression signatures: a report from The activated B-cell subtype of diffuse large B-cell lymphoma and MYC/BCL2 protein coexpression contributes to the inferior survival of - 字舞流文

International DLBCL Rituximab-CHOP Consortium Program demonstrates high-risk gene expression signatures: a report from The activated B-cell subtype of diffuse large B-cell lymphoma and MYC/BCL2 protein coexpression contributes to the inferior survival of

W. Choi | R. Gascoyne | G. Slack | M. Piris | Wei-min Liu | G. Bhagat | Fan Zhou | K. Young | Z. Xu-Monette | L. Medeiros | K. Richards | M. Møller | S. Montes-Moreno | C. Visco | E. Hsi | M. Ponzoni | Yong Li | R. Miranda | K. Dybkaer | R. Go | A. Tzankov | A. Orazi | Shimin Hu | Qin Huang | Lin Wu | A. Balasubramanyam | J. Krieken | J. Ferreri | T. Green | M. Ponzoni | L. Medeiros | Ken H Young | Roberto N. Miranda | E. D. Hsi | Shimin Hu | Lin Wu | Wei-min Liu | Qin Huang | Fan Zhou | Ronald S. Go | J. V. Krieken | J. M. Ferreri